Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: Summary of a 1999 symposium

Clinica Chimica Acta

Volumn 303, Issue 1-2, 2001, Pages 1-17

  Hicks, Jocelyn M ^a   Haeckel, Rainer ^b   Price, Christopher P ^c   Lewandrowski, Kent ^d   Wu, Alan H B ^e  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b Bremer Zentrum fur Laboratoriumsmedizin   (Germany)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e HARTFORD HOSPITAL   (United States)

Author keywords

Arterial blood gases; Cardiac markers; Drugs of abuse testing; Glucose; Point of care testing; Turnaround times

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; ESTERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ACCURACY; AMBULANCE; ARTERIAL GAS; BLOOD CLOTTING TEST; CONSULTATION; DRUG ABUSE; DYSPEPSIA; FIRST AID; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE QUALITY; HELICOBACTER PYLORI; HUMAN; PATIENT MONITORING; PREGNANCY DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUALITY CONTROL; REVIEW; SCREENING TEST; SYMPOSIUM; TREATMENT INDICATION; TREATMENT PLANNING; URINARY TRACT DISEASE;

LABORATORIES, HOSPITAL; POINT-OF-CARE SYSTEMS; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY;

EID: 0035142950     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00400-9     Document Type: Review

References (56)

1. Laboratory medicine in the United Kingdom: 1948-1998 and beyond
2. The laboratory clinical interface: Point-of-care testing
3. Reengineering the clinical laboratory
4. The portable laboratory: An evaluation of the accuracy and reproducibility of i-STAT
5. Automated approaches to rapid response testing: Comparative evaluation of point-of-care and centralized laboratory testing
6. Laboratory process improvement through point-of-care testing
7. The need for a point of care testing: An evidence-based appraisal
8. Cost analysis. Bedside blood glucose
9. Cost implications of decentralized testing - A laboratorian' s view
10. Point-of-care testing outcomes in an emergency department
11. Point of care testing: Randomized controlled trial of clinical outcome
12. Evaluating stat testing options in an academic health center: Therapeutic turnaround time and staff satisfaction
13. Near patient blood glucose monitoring
14. Cost analysis of point-of-care laboratory testing in a community hospital
15. Impact of point-of-care testing on patients' length of stay in a large emergency department
16. Quantification of medical and operational factors determining central vs. satellite laboratory testing of blood gases
17. The fiscal consequences of central vs. distributed testing of glucose
18. Use of bedside activated partial thromboplastin time monitor to adjust heparin dosing after thrombolysis for acute myocardial infarction: Results of GUSTO-I
19. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease
20. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting
21. Desirable performance standards for imprecision and bias in alternate sites
22. Evaluating clinical accuracy of systems for self-monitoring of blood glucose
23. Patient and physician analytic goals for self-monitoring blood glucose instruments
24. New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose
25. Extra-laboratory blood glucose measurement: A policy statement
26. Point-of-care glucose testing: Effects of critical care variables, influence of reference instruments, and a modular glucose meter design
27. Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer
28. Guidelines on point-of-care testing
29. Guidelines for near patient testing: Hematology
30. Measuring the effects of imaging: An evaluative framework
31. Health technology assessment and the NHS R & D initiative
32. A review of near patient testing in primary care
33. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
34. Diabetes control in general practice: Meta-analysis of randomized control trials
35. Self-monitoring of blood glucose
36. Self monitoring of blood glucose
37. Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation
38. Neonatal morbidities in infants of mothers with glucose intolerance in pregnancy
39. Gestational diabetes mellitus: Is further improvement necessary?
40. Multicenter survey of diabetic pregnancy in France
41. Glucose tolerance test: Degree of glucose abnormality correlates with neonatal outcome
42. Intensified vs. conventional management of gestational diabetes
43. Impact of introducing near-patient testing for standard investigations in general practice
44. The validity of urine examination for urinary tract infections in daily practice
45. Point of care testing in hematology
46. Evaluation of a primary care anticoagulant clinic managed by a pharmacist
47. A role for community pharmacists in the control of anticoagulant therapy
48. An evaluation of near-patient testing for Helicobacter pylori in general practice
49. New chest pain strategy in Thunder Bay
50. The patient with chest pain
51. The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective randomized evaluation in patients undergoing cardiac operations
52. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation
53. Clinical drug testing at the point-of-care
54. Evaluation of a portable clinical blood analyzer in the emergency department